Clinical Trial Update: A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated inhaled PT007 (AS MDI) against placebo MDI and Ventolin Evohaler to assess lung function in adults with asthma; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT007 (AS MDI) (PT007)
• Placebo MDI
• Ventolin Evohaler (albuterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED